Precore mutation of hepatitis B virus may be associated with low breakthrough rate following long-term lamivudine therapy in patients with chronic hepatitis B

被引：0
|
作者：
Ryu, SH [1 ]
Chung, YH [1 ]
Choi, MH [1 ]
Kim, JA [1 ]
Shin, JW [1 ]
Jang, MK [1 ]
Park, NH [1 ]
Lee, HC [1 ]
Lee, YS [1 ]
Suh, DJ [1 ]
机构：
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Seoul, South Korea
来源：
HEPATOLOGY | 2002年 / 36卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1917
引用
收藏
页码：642A / 642A
页数：1
相关论文
共 50 条
  • [21] Interferon for treatment of breakthrough infection with hepatitis B virus mutants developing during long-term lamivudine therapy
    Suzuki, F
    Tsubota, A
    Akuta, N
    Someya, T
    Kobayashi, M
    Suzuki, Y
    Saitoh, S
    Arase, Y
    Ikeda, K
    Miyakawa, Y
    Kumada, H
    JOURNAL OF GASTROENTEROLOGY, 2002, 37 (11) : 922 - 927
  • [22] Interferon for treatment of breakthrough infection with hepatitis B virus mutants developing during long-term lamivudine therapy
    Fumitaka Suzuki
    Akihito Tsubota
    Norio Akuta
    Takashi Someya
    Masahiro Kobayashi
    Yoshiyuki Suzuki
    Satoshi Saitoh
    Yasuji Arase
    Kenji Ikeda
    Yuzo Miyakawa
    Hiromitsu Kumada
    Journal of Gastroenterology, 2002, 37 : 922 - 927
  • [23] THE ROLE OF PRECORE HEPATITIS-B VIRUS MUTANTS ON THE LONG-TERM OUTCOME OF CHRONIC HEPATITIS-B VIRUS HEPATITIS - A LONGITUDINAL-STUDY
    LAI, ME
    SOLINAS, A
    MAZZOLENI, AP
    DEPLANO, A
    FARCI, P
    LISCI, V
    PORRU, A
    TOCCO, A
    BALESTRIERI, A
    JOURNAL OF HEPATOLOGY, 1994, 20 (06) : 773 - 781
  • [24] Efficacy of long-term lamivudine therapy in HBeAg negative chronic hepatitis B
    Dimou, E
    Papatheodoridis, GC
    Laras, A
    Rapti, I
    Dourakis, S
    Hadziyannis, SJ
    HEPATOLOGY, 1999, 30 (04) : 646A - 646A
  • [25] Long-term therapy with lamivudine in renal transplant recipients with chronic hepatitis B
    Thabut, D
    Thibault, V
    Bernard-Chabert, B
    Mouquet, C
    Di Martino, V
    Le Calvez, S
    Opolon, P
    Benhamou, Y
    Bitker, MO
    Poynard, T
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2004, 16 (12) : 1367 - 1373
  • [26] Interferon therapy for fulminant hepatitis associated with precore region mutation in hepatitis B virus carrier
    Omata, F
    Ide, H
    Ito, T
    Shibayama, Y
    Takahashi, H
    Ueno, F
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1996, 91 (08): : 1673 - 1675
  • [27] YMDD mutation in Chinese: Patients following lamivudine therapy for chronic hepatitis B infection
    Yao, GB
    GASTROENTEROLOGY, 1999, 116 (04) : A848 - A849
  • [28] Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy
    Yuen, MF
    Sablon, E
    Hui, CK
    Yuan, HJ
    Decraemer, H
    Lai, CL
    HEPATOLOGY, 2001, 34 (04) : 785 - 791
  • [29] Long-term lamivudine therapy in hepatitis B-associated membranous nephropathy?
    Ng, YY
    Yang, WC
    Lee, ST
    KIDNEY INTERNATIONAL, 2006, 69 (04) : 776 - 776
  • [30] Viral breakthrough during lamivudine therapy for chronic hepatitis B
    Leung, N
    INTERVIROLOGY, 2003, 46 (06) : 344 - 349
12345